TETRACYCLINE 3% price in UAE

Overview

Welcome to Dwaey, specifically on TETRACYCLINE 3% Ointment page.
This medicine contains an important and useful components, as it consists of Tetracycline.
TETRACYCLINE 3% is available in the market in concentration 30mg/g and in the form of Ointment.

JULPHAR (GULF PHARMACEUTICAL INDUSTRIES) is the producer of TETRACYCLINE 3% and it is imported from UAE, The most popular alternatives of TETRACYCLINE 3% are listed downward .

Mode Of Action

Tetracycline exhibits its bacteriostatic action by reversibly binding to the 30S subunits of the ribosome, thus preventing protein synthesis and arresting cell growth. It has a broad spectrum of antimicrobial activity including Chlamydiaceae, Mycoplasma spp., Rickettsia spp., spirochaetes, many aerobic and anaerobic gm+ve and gm-ve pathogenic bacteria and some protozoa.

Indication

Acne
Lyme disease
Uncomplicated gonorrhea
Syphilis
Psittacosis
Q fever
Pleural effusions
Rocky Mountain spotted fever
Lymphogranuloma venereum
Mycoplasma pneumoniae
Trachoma
Nongonococcal urethritis

Precaution

Patient w/ pre-existing SLE, myasthenia gravis. Hepatic and mild to moderate renal impairment. Pregnancy. Patient Counselling Avoid direct exposure to sunlight or UV light. Monitoring Parameters Monitor renal, hepatic and haematologic function test, temp, WBC, cultures and sensitivity, appetite, mental status.

Side Effects

>10% Discoloration of teeth and enamel hypoplasia (young children) 1-10% Diarrhea
Nausea
Photosensitivity <1% Anorexia
Abdominal cramps
Antibiotic-associated pseudomembranous colitis
Bulging fontanels in infants
Diabetes insipidus syndrome
Esophagitis
Exfoliative dermatitis
Incr ICP
Pericarditis
Pseudotumor cerebri
Pancreatitis
Pruritus
Pigmentation of nails
Vomiting Potentially Fatal: Anaphylaxis
hepatotoxicity
nephrotoxicity
blood dyscrasias.

Contra indication

Hypersensitivity; pregnancy, lactation, children; renal impairment.

Pregnancy and lactation

Pregnancy category: D

There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

Interaction

Impaired absorption w/ antacids containing divalent and trivalent cations (e.g. Al, Ca, Mg), Fe, Zn and Na bicarbonate preparations, kaolin-pectin, bismuth subsalicylate, sucralfate, strontium ranelate, colestipol and colestyramine. May interfere w/ the bactericidal action of penicillin. May potentiate the effect of anticoagulants. May decrease efficacy of oral contraceptives. Nephrotoxic effects may be exacerbated by diuretics or other nephrotoxic drugs. May increase the hypoglycaemic effect of insulin and sulfonylureas in patients w/ DM. May increase toxic effects of ergot alkaloids and methotrexate. Potentially Fatal: Concurrent methoxyflurane may result to fatal renal toxicity. Increased risk of benign intracranial HTN w/ vit A or retinoids (e.g. acitretin,isotretinoin, tretinoin).